Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: Andrew T who wrote (497)	3/4/1998 10:20:00 PM
From: Brad	Respond to of 4650

Hi Andrew! Biomoda didn't discover anything by themselves. BUT, they HAVE hold a world-wide exclusive license in perpetuity from the University of California to a patented a molecular marker/binder technology for the very early detection of lung cancer AND an integrated treatment for lung cancer (as described in your post). Essentially, Biomoda holds the key here. And ADOT owns at least 20% of Biomoda. Best wishes, Brad

To: Andrew T who wrote (497)	3/4/1998 10:26:00 PM
From: Jeffrey Beckman	Read Replies (1) \| Respond to of 4650

Andrew, Brad and all, I think I understand Biomoda's proposed mechanism for diagnosis and treatment, all of which sounds plausible. I was just a bit confused in one area. It sounded from Andrew's description as if existing equipment is capable of detecting the TCPP by a number of means. Where does ADOT's scanning technology (mentioned in Brad's summary) come into play, and how is it an improvement. Thanks for the excellent posts, Jeff

To: Andrew T who wrote (497)	3/5/1998 12:50:00 AM
From: dennis reed	Read Replies (1) \| Respond to of 4650

Dear Andrew T, Thank you for the excellent post! Could you purpose a time line re the steps needing to be completed to get at least the testing phase to mkt.And the colateral question is on the tmt side. Also,do you have an opinion on the side of early diagnosis without a corresponding tmt.as it relates to human value. best dennis reed

To: Andrew T who wrote (497)	3/5/1998 7:59:00 AM
From: Wink	Respond to of 4650

Nice write up Andrew. Looks like a winner for the company and all those smokers out there. ;>)